Back to User profile » Dr Cheng-Yu Chang
Papers published by Dr Cheng-Yu Chang:
Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer
Chen CY, Ko HW, Hu PW, Chang CY, Chen CY, Chang SC, Chiu YC, Wei YF
Lung Cancer: Targets and Therapy 2025, 16:25-37
Published Date: 12 April 2025
Efficacy and Prognosis of First-Line EGFR-Tyrosine Kinase Inhibitor Treatment in Older Adults Including Poor Performance Status Patients with EGFR-Mutated Non-Small-Cell Lung Cancer
Chang CY, Chen CY, Chang SC, Lai YC, Wei YF
Cancer Management and Research 2021, 13:7187-7201
Published Date: 15 September 2021
PD-L1 Expression and Outcome in Patients with Metastatic Non-Small Cell Lung Cancer and EGFR Mutations Receiving EGFR-TKI as Frontline Treatment
Chang CY, Lai YC, Wei YF, Chen CY, Chang SC
OncoTargets and Therapy 2021, 14:2301-2309
Published Date: 31 March 2021
Docetaxel-related interstitial pneumonitis
Wang CJ, Chang HT, Chang CY
Therapeutics and Clinical Risk Management 2015, 11:1813-1816
Published Date: 9 December 2015
Risk factors in patients with AFB smear-positive sputum who receive inappropriate antituberculous treatment
Chang CY, Hong JY, Yuan MK, Chang SJ, Lee YM, Chang SC, Hsu LC, Cheng SL
Drug Design, Development and Therapy 2013, 7:53-58
Published Date: 31 January 2013